#news #biotech Vernalis, weakened by FDA rejections, accepts £33M Ligand bid 

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vernalis, weakened by FDA rejections, accepts £33M Ligand bid  .Ligand Pharmaceuticals is set to acquire Vernalis for the knockdown price of £33 million ($42 million). The takeover agreement comes one year after Vernalis was left reeling by a second FDA rejection in quick succession.

from FierceBiotech: Biotech https://ift.tt/2OYQlsf